News & Updates

Risk of colorectal cancer mortality after adenoma removal differs by sex

02 Feb 2022

Women appear to be at higher risk of colorectal cancer death following adenoma removal, whereas men are at lower risk, as reported in a recent study.

Risk of colorectal cancer mortality after adenoma removal differs by sex

02 Feb 2022

Effect of interventions on anthropometric outcomes in PCOS varies by drug

02 Feb 2022

In the management of women with polycystic ovary syndrome (PCOS), metformin at various therapeutic doses appears to reduce body weight, body mass index, and waist circumference when compared with placebo, sitagliptin, and acarbose, according to the results of a meta-analysis. On the other hand, pioglitazone and rosiglitazone contribute to an increase in all three outcomes.

Effect of interventions on anthropometric outcomes in PCOS varies by drug

02 Feb 2022

Waist circumference, not BMI, a good indicator of outcomes in older diabetics

02 Feb 2022

In older patients with type 2 diabetes (T2D), use of body mass index (BMI) does not adequately predict clinical outcomes associated with obesity, but waist circumference (WC) appears to be up to the task.

Waist circumference, not BMI, a good indicator of outcomes in older diabetics

02 Feb 2022

Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT

02 Feb 2022

An exercise and dietary lifestyle intervention regimen leads to better mobility outcomes among prostate cancer patients undergoing androgen deprivation therapy (ADT) as compared with standard-of-care management, a recent study has found. Moreover, social cognitive outcome measures seem to be predictive of such mobility outcomes.

Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT

02 Feb 2022

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

01 Feb 2022

At a dose of 6 mg, brolucizumab yields substantial visual gains and anatomical improvements in patients with diabetic macular oedema without increasing the risk of serious adverse ocular events when compared with aflibercept, according to data from two phase III trials.

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

01 Feb 2022

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

01 Feb 2022 by

Continuous exposure to radiation during cancer therapy promotes ulceration of tissues or radionecrosis, and a recent study revealed that the use of low-level light therapy may accelerate the resolution of skin damage by up to 50 percent.

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

01 Feb 2022

High haemoglobin glycation index tied to telomere attrition

01 Feb 2022

A negative association exists between haemoglobin glycation index (HGI) and telomere attrition, independent of HbA1c, according to a study. Tumour necrosis factor (TNF) α mediates the association between HGI and telomere length.

High haemoglobin glycation index tied to telomere attrition

01 Feb 2022

Persistent dysglycaemia dims tuberculosis treatment outcomes

01 Feb 2022

Among patients with tuberculosis (TB) infection, treatment outcomes seem unfavourable in the presence of persistent dysglycaemia, as reported in a study.

Persistent dysglycaemia dims tuberculosis treatment outcomes

01 Feb 2022

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

01 Feb 2022

KVD900, and oral inhibitor of plasma kallikrein (PKa), safely and rapidly induces near-complete PKa inhibition, reports two phase I studies.

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

01 Feb 2022

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients

31 Jan 2022

Among teens and adults with congenital adrenal hyperplasia (CAH), adherence to treatment regimens, rather than type of glucocorticoid, is the factor that affects quality of life (QoL), according to a study.

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients

31 Jan 2022

News & Updates

Filter by Specialty:

Specialty:

Risk of colorectal cancer mortality after adenoma removal differs by sex

Risk of colorectal cancer mortality after adenoma removal differs by sex

Effect of interventions on anthropometric outcomes in PCOS varies by drug

Effect of interventions on anthropometric outcomes in PCOS varies by drug

Waist circumference, not BMI, a good indicator of outcomes in older diabetics

Waist circumference, not BMI, a good indicator of outcomes in older diabetics

Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT

Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

Brolucizumab shows favourable benefit–risk profile in diabetic macular oedema

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

Low-level light therapy may speed up repair of radiation therapy-induced skin damage

High haemoglobin glycation index tied to telomere attrition

High haemoglobin glycation index tied to telomere attrition

Persistent dysglycaemia dims tuberculosis treatment outcomes

Persistent dysglycaemia dims tuberculosis treatment outcomes

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

KVD900 shows promise in early trial, gives hope to hereditary angioedema patients

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients

Treatment adherence yields QoL gains in congenital adrenal hyperplasia patients